Capital World Investors
BIO icon

Capital World Investors’s Bio-Rad Laboratories Class A BIO Stock Holding History

Capital World Investors’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$136M Buy
462,457
+12,457
+3% +$3.53M 0.02% 370
2026
Q1 		$125M Buy
+450,000
New +$130M 0.02% 358

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Capital World Investors's BIO Position: Q2 2026 in Review

Capital World Investors increased its Bio-Rad Laboratories Class A (BIO) stake by 2.8% in Q2 2026, buying an estimated $3.53M and bringing the position to 462,457 shares worth $136M. The position accounts for 0.02% of the portfolio, ranked #370.

Capital World Investors first reported a position in BIO in Q1 2026 and has held it in 2 quarters since. 398 funds tracked by Wall St. Rank hold BIO as of Q2 2026.

  • Capital World Investors held 462,457 shares of Bio-Rad Laboratories Class A worth $136M as of Q2 2026.
  • Capital World Investors bought 12,457 Bio-Rad Laboratories Class A shares in Q2 2026, an estimated $3.53M.
  • Bio-Rad Laboratories Class A made up 0.02% of Capital World Investors's portfolio in Q2 2026, its #370 holding.
  • Capital World Investors first reported a position in Bio-Rad Laboratories Class A in Q1 2026 and has held it in 2 quarters since.
  • 398 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2026.

Based on Capital World Investors's 13F filing for Q2 2026, filed 12 Aug 2026.